210 related articles for article (PubMed ID: 19240073)
1. Role of TolC in Klebsiella oxytoca resistance to antibiotics.
Fenosa A; Fusté E; Ruiz L; Veiga-Crespo P; Vinuesa T; Guallar V; Villa TG; Viñas M
J Antimicrob Chemother; 2009 Apr; 63(4):668-74. PubMed ID: 19240073
[TBL] [Abstract][Full Text] [Related]
2. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coli.
de Cristóbal RE; Vincent PA; Salomón RA
J Antimicrob Chemother; 2006 Jul; 58(1):31-6. PubMed ID: 16687460
[TBL] [Abstract][Full Text] [Related]
4. HasF, a TolC-homolog of Serratia marcescens, is involved in energy-dependent efflux.
Kumar A; Worobec EA
Can J Microbiol; 2005 Jun; 51(6):497-500. PubMed ID: 16121228
[TBL] [Abstract][Full Text] [Related]
5. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli.
Gerken H; Misra R
Mol Microbiol; 2004 Nov; 54(3):620-31. PubMed ID: 15491355
[TBL] [Abstract][Full Text] [Related]
6. Salt-inducible multidrug efflux pump protein in the moderately halophilic bacterium Chromohalobacter sp.
Tokunaga H; Mitsuo K; Ichinose S; Omori A; Ventosa A; Nakae T; Tokunaga M
Appl Environ Microbiol; 2004 Aug; 70(8):4424-31. PubMed ID: 15294769
[TBL] [Abstract][Full Text] [Related]
7. TolC dependency of multidrug efflux systems in Salmonella enterica serovar Typhimurium.
Horiyama T; Yamaguchi A; Nishino K
J Antimicrob Chemother; 2010 Jul; 65(7):1372-6. PubMed ID: 20495209
[TBL] [Abstract][Full Text] [Related]
8. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of higher MICs of antibiotics and quaternary ammonium compounds for Escherichia coli isolated from bacteraemia.
Buffet-Bataillon S; Le Jeune A; Le Gall-David S; Bonnaure-Mallet M; Jolivet-Gougeon A
J Antimicrob Chemother; 2012 Dec; 67(12):2837-42. PubMed ID: 22904241
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli.
Liu J; Keelan P; Bennett PM; Enne VI
J Antimicrob Chemother; 2009 Mar; 63(3):423-6. PubMed ID: 19131424
[TBL] [Abstract][Full Text] [Related]
11. The TolC protein of Escherichia coli serves as a cell-surface receptor for the newly characterized TLS bacteriophage.
German GJ; Misra R
J Mol Biol; 2001 May; 308(4):579-85. PubMed ID: 11350161
[TBL] [Abstract][Full Text] [Related]
12. The outer membrane TolC is involved in cysteine tolerance and overproduction in Escherichia coli.
Wiriyathanawudhiwong N; Ohtsu I; Li ZD; Mori H; Takagi H
Appl Microbiol Biotechnol; 2009 Jan; 81(5):903-13. PubMed ID: 18828007
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a chromosomal nickel resistance determinant from Klebsiella oxytoca CCUG 15788.
Park JS; Lee SJ; Rhie HG; Lee HS
J Microbiol Biotechnol; 2008 Jun; 18(6):1040-3. PubMed ID: 18600044
[TBL] [Abstract][Full Text] [Related]
14. Studies on the region involved in the transport activity of Escherichia coli TolC by chimeric protein analysis.
Yamanaka H; Tadokoro S; Miyano M; Takahashi E; Kobayashi H; Okamoto K
Microb Pathog; 2007; 42(5-6):184-92. PubMed ID: 17350794
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance in clinical isolates of Klebsiella oxytoca.
Horii T; Osaki M; Muramatsu H
Chemotherapy; 2008; 54(4):323-7. PubMed ID: 18698136
[TBL] [Abstract][Full Text] [Related]
16. Role of the AraC-XylS family regulator YdeO in multi-drug resistance of Escherichia coli.
Nishino K; Senda Y; Hayashi-Nishino M; Yamaguchi A
J Antibiot (Tokyo); 2009 May; 62(5):251-7. PubMed ID: 19329985
[TBL] [Abstract][Full Text] [Related]
17. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
Zhou X; Jia F; Liu X; Wang Y
Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
[TBL] [Abstract][Full Text] [Related]
18. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli.
Hansen LH; Johannesen E; Burmølle M; Sørensen AH; Sørensen SJ
Antimicrob Agents Chemother; 2004 Sep; 48(9):3332-7. PubMed ID: 15328093
[TBL] [Abstract][Full Text] [Related]
19. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
[TBL] [Abstract][Full Text] [Related]
20. Directed evolution of a bacterial efflux pump: adaptation of the E. coli TolC exit duct to the Pseudomonas MexAB translocase.
Bokma E; Koronakis E; Lobedanz S; Hughes C; Koronakis V
FEBS Lett; 2006 Oct; 580(22):5339-43. PubMed ID: 16979625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
